$4.28 -0.05 (%) Agenus Inc - NASDAQ

Dec. 9, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. AGENUS

    IBD | Dec. 23, 2015 | 18:45PM EST
  2. Agenus Inc. Completes $115M Non-Dilutive Royalty Transaction with Oberland Capital

    Benzinga | Sep. 9, 2015 | 06:02AM EST
  3. Paul Tudor Jones' Highest Performing Stocks

    GuruFocus | Jul. 13, 2015 | 15:16PM EST
  4. Did Anyone Notice Sucampo's Breakout?

    Benzinga | Jul. 13, 2015 | 14:09PM EST
  5. Benzinga's Top Initiations

    Benzinga | Jun. 11, 2015 | 09:04AM EST
  6. US Stock Futures Surge Ahead Of ADP Report, Beige Book

    Benzinga | Jun. 3, 2015 | 06:30AM EST
  7. Merck Extends Immuno-Oncology Collaboration with Agenus

    Benzinga | Jun. 3, 2015 | 06:03AM EST
  8. Updated Phase 2 Data of Prophage In Newly Diagnosed GBM Presented at ASCO Show Improvement in Median Progression Free Survival and Overall Survival Independently of Prognostic Markers, Compared with Historical Expectations

    Benzinga | Jun. 1, 2015 | 06:04AM EST
  9. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  10. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  11. Mid-Afternoon Market Update: Five Below Slips On Weak Outlook; Agenus Shares Spike Higher

    Benzinga | Jan. 9, 2015 | 15:41PM EST
  12. Mid-Day Market Update: Dow Dips 1%; Acuity Brands Shares Jump On Earnings Beat

    Benzinga | Jan. 9, 2015 | 13:33PM EST
  13. Mid-Morning Market Update: Markets Decline; Infosys Posts Higher Profit

    Benzinga | Jan. 9, 2015 | 10:49AM EST
  14. Morning Market Gainers

    Benzinga | Jan. 9, 2015 | 09:43AM EST
  15. Morning Market Movers

    Benzinga | Dec. 18, 2014 | 09:40AM EST
  16. #PreMarket Movers From December 18, 2014: Rite Aid, Oracle, GoPro And More

    Benzinga | Dec. 18, 2014 | 09:08AM EST
  17. Agenus Inc - A Potential New Play On Ebola

    Benzinga | Oct. 13, 2014 | 12:01PM EST
  18. Agenus Inc.: Ingeniously Designed Vaccines To Galvanized Tomorrow's Medicine

    GuruFocus | Jul. 25, 2014 | 10:07AM EST
  19. Morning Market Movers

    Benzinga | Jul. 1, 2014 | 08:35AM EST
  20. US Stock Futures Gain Ahead Of Manufacturing PMI, Auto Sales

    Benzinga | Jul. 1, 2014 | 06:35AM EST
  21. UPDATE: Agenus Announces Positive Phase 2 Results

    Benzinga | Jul. 1, 2014 | 06:03AM EST
  22. Morning Market Movers

    Benzinga | Jun. 26, 2014 | 08:37AM EST
  23. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 26, 2014 | 07:15AM EST
  24. UPDATE: Agenus Vaccine Shows Significant Reduction in Viral Burden after HerpV Generated Immune Activation

    Benzinga | Jun. 26, 2014 | 06:01AM EST
  25. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 17:25PM EST
  26. Morning Market Losers

    Benzinga | Apr. 2, 2014 | 08:55AM EST
  27. Glaxo Cancer Vaccine Fails, Testing Continues

    FoxBusiness | Mar. 20, 2014 | 08:59AM EST
  28. Morning Market Losers

    Benzinga | Mar. 20, 2014 | 08:46AM EST
  29. US Stock Futures Drop Ahead Of Jobless Claims Report

    Benzinga | Mar. 20, 2014 | 06:25AM EST
  30. Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does Not Meet First or Second Primary Endpoint

    Benzinga | Mar. 20, 2014 | 05:12AM EST
  31. UPDATE: H.C. Wainwright & Co. Initiates Coverage on Agenus Following 4-Antibody Acquisition

    Benzinga | Feb. 24, 2014 | 07:55AM EST
  32. Agenus Announces Public Offering of Common Stock

    Benzinga | Feb. 4, 2014 | 17:05PM EST
  33. Agenus Names Robert B. Stein as Chief Scientific Officer

    Benzinga | Jan. 13, 2014 | 07:20AM EST
  34. Agenus to Acquire Privately Held 4-Antibody AG for $10M in Stock

    Benzinga | Jan. 13, 2014 | 07:11AM EST
  35. Agenus Announces Positive Phase 2 Brain Cancer Vaccine Results Published in Neuro-Oncology

    Benzinga | Dec. 16, 2013 | 07:04AM EST
  36. Agenus' HerpV Therapeutic Genital Herpes Vaccine Meets Primary Endpoint in Randomized Phase 2 Trial

    Benzinga | Nov. 7, 2013 | 07:05AM EST
  37. Morning Market Movers

    Benzinga | Oct. 8, 2013 | 08:53AM EST
  38. Agenus Enters into Non-Exclusive License Agreement with VaxLogic for QS-21 Stimulon1 Adjuvant

    Benzinga | Sep. 26, 2013 | 06:03AM EST
  39. Morning Market Movers

    Benzinga | Sep. 17, 2013 | 08:53AM EST
  40. Agenus Reports Positive Follow-on Phase 2 Results for Brain Cancer Vaccine

    Benzinga | Sep. 17, 2013 | 06:04AM EST
  41. Morning Market Losers

    Benzinga | Sep. 5, 2013 | 09:03AM EST
  42. GlaxoSmithKline's Phase 3 Malaria Vaccine Study Meets Primary Endpoint

    Benzinga | Nov. 8, 2012 | 23:07PM EST
  43. Antigenics Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 03:36AM EST
  44. Agenus Initiates Phase 2 Study of Genital Herpes Vaccine

    Benzinga | Oct. 23, 2012 | 00:18AM EST
  45. Aeras Signs Agreement with GSK to Jointly Develop TB Vaccine

    Benzinga | Oct. 9, 2012 | 23:18PM EST
  46. Antigenics Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 8, 2012 | 06:20AM EST
  47. 5 Speculative Biotech Stocks to Consider Buying Now

    GuruFocus | Jan. 24, 2012 | 11:09AM EST
  48. Antigenics Inc. (AGEN) CFO Shalini Sharp sells 4,564 Shares

    GuruFocus | Dec. 29, 2011 | 10:17AM EST
  49. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 29, 2011 | 03:25AM EST
  50. A Peek Into The Market Before The Trading Starts

    Benzinga | Dec. 20, 2011 | 00:13AM EST
Trading Center